Global Clinical Trial Imaging Market Size, Study, by Product, Application and Forecasts 2023-2029

James Grey

Global Clinical Trial Imaging Market Size, Study, by Product, Application and Forecasts 2023-2029

Bharat Book Bureau Provides the Trending Market Research Report on “Global Clinical Trial Imaging Market 2023-2029”under Life Sciences Market Research Report Category. The report offers a collection of superior Market research, Market analysis, competitive intelligence and Market reports.

The global Clinical Trial Imaging Market will grow from USD 1,176 million in 2022 to USD 1,669 million by 2029, achieving a compound annual growth rate (CAGR) of 5.2 percent. Imaging was identified as one of the components that could play an important role in reducing the cost of clinical trials, which is a major component of drug approval costs. In particular, using time-to-progression (often detected by imaging) rather than survival as the outcome measure can reduce costs and improve timeliness.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global clinical trial imaging market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the service, application, end user, and region. The global market for clinical trial imaging can be segmented by service: clinical trial design and consultation services, operational imaging services, project and data management services, reading and analytical services, system and technology support services, others. The project and data management services segment held the largest share of the global clinical trial imaging market in 2022 and is anticipated to hold its share during the forecast period. Clinical trial imaging market is further segmented by application: cardiology, endocrinology, gastroenterology, neurology, oncology, others. Globally, the oncology segment made up the largest share of the clinical trial imaging market. Based on end user, the clinical trial imaging market is segmented into: academia and research institutes, contract research organizations (CROs), medical device companies, pharmaceutical & biotechnology companies, others. The CROs segment was the largest contributor to the global clinical trial imaging market in 2022. On the basis of region, the clinical trial imaging market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America is estimated to account for the largest share of the global clinical trial imaging market.

Market Segmentation

By service: clinical trial design and consultation services, operational imaging services, project and data management services, reading and analytical services, system and technology support services, others

By application: cardiology, endocrinology, gastroenterology, neurology, oncology, others

By end user: academia and research institutes, contract research organizations (CROs), medical device companies, pharmaceutical & biotechnology companies, others

By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The global clinical trial imaging market report offers detailed information on several market vendors, including Biospective Inc., Biotelemetry Inc. (Koninklijke Philips N.V.), Cardiovascular Imaging Technologies LLC (CVIT), ERT + Bioclinica, Inc. (Clario), ICON plc, Imaging Endpoints II LLC, Intrinsic Imaging LLC (WIRB - Copernicus Group, Inc.), IXICO plc, Median Technologies S.A., Medical Metrics Inc. (Catalent, Inc.), Medpace Holdings, Inc., Micron Inc., Parexel International Corporation, Perceptive Informatics, LLC D/B/A Calyx, pharmtrace klinische Entwicklung GmbH, Prism Clinical Imaging, Inc., ProScan Imaging LLC, Radiant Sage LLC, Resonance Health Ltd., WorldCare Clinical, LLC, among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Scope of the Report

• To analyze and forecast the market size of the global clinical trial imaging market.

• To classify and forecast the global clinical trial imaging market based on service, application, end user, region.

• To identify drivers and challenges for the global clinical trial imaging market.

• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global clinical trial imaging market.

• To identify and analyze the profile of leading players operating in the global clinical trial imaging market.

Why Choose This Report

• Gain a reliable outlook of the global clinical trial imaging market forecasts from 2023 to 2029 across scenarios.

• Identify growth segments for investment.

• Stay ahead of competitors through company profiles and market data.

• The market estimate for ease of analysis across scenarios in Excel format.

• Strategy consulting and research support for three months.

• Print authentication provided for the single-user license.

Browse our full report with Table of Content :

https://www.bharatbook.com/report/1398111/global-clinical-trial-imaging-market

About Bharat Book Bureau:

Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,00,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ sub sectors.

Contact us at:

Bharat Book Bureau

Tel: +91 22 27810772 / 27810773

Email: [email protected]

Website: www.bharatbook.com

James Grey

Clinical Trial Imaging Market Growth 2023- Global Industry Share, Growing Demand, Revenue, Scope, CAGR Status, Business Challenges and Future Strategies Report 2033: SPER Market Research

varsha shrivastav 2023-07-26

The need for clinical trial imaging services is driven by compliance with regulatory regulations from organisations like the FDA and EMA. The demand for imaging services in clinical trials is anticipated to increase as personalised medicine, which uses imaging for patient-specific characteristics, comes into greater focus. In addition, the increased need for clinical trial imaging services is a result of clinical trials' geographic expansion, particularly in developing economies. sample=1Impact of COVID-19 on Global Clinical Trial Imaging Market Clinical trials were significantly disrupted by the COVID-19 pandemic, which reduced their number and affected the market for clinical trial imaging services. Furthermore, the projected period anticipates a surge in demand for Clinical Trial Imaging accompanied by increased R&D spending and an expansion of CROs for best imaging modalities.

Clinical Trial Imaging Market Analysis and Forecast 2023-2029

Aishwarya Bhasme 2023-10-26

1 Global Clinical Trial Imaging Market, by Product and Service (2021-2029)• Trial Design Consulting Services• Read Analysis Services• Operational Imaging Services• Imaging Software2 Global Clinical Trial Imaging Market, by Modality (2021-2029)• Magnetic Resonance Imaging• Computed Tomography• Ultrasound• Positron Emission Tomography• X-Ray• Echocardiography• Other Modalities3 Global Clinical Trial Imaging Market, by End-User (2021-2029)• Pharmaceutical Companies• Medical Device Manufacturers• Academic and Government Research Institutes• Other End-Users4 Global Clinical Trial Imaging Market, by Application (2021-2029)• Nonalcoholic Steatohepatitis (NASH)• Chronic Kidney Disease (CKD)• Cardiovascular Diseases• OthersFor any Queries Linked with the Report, Ask an Analyst@ https://www. What is the forecast period of the Clinical Trial Imaging Market? Which region held the largest market share in the Clinical Trial Imaging Market? What are the opportunities for the Clinical Trial Imaging Market? Price TrendsKey Opinion Leaders OfferingsGovernment InitiativesAbout Maximize Market Research:Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries.

Clinical Trial Imaging Services Market Procurement Intelligence Business Opportunities With Top Key Players Till 2025

researchinsights 2021-12-27

The core clinical imaging solution include protocol design, site selection, site training and support, electronic image transfer and de-identification, certified radiologic technologist image QC, independent blinded image review, clinical data management and biostatistics, preparation for audits, and regulatory and compliance decisions. North America accounted for the major share of the clinical trial imaging services market and is expected to continue this trend owing to the surge in use of imaging as an endpoint in clinical trials which leads to sponsors outsourcing these services to save cost. Intrinsic Imaging LLC leads to easy availability of clinical trial imaging service, which in turn boosts the growth of the market in the region. Browse our other Reports:Conveyor Belts Market Procurement Intelligence, Supplier Intelligence, Supplier Ranking, Pricing & Cost Structure Intelligence, Best Practices, Engagement Model, Low & Best Cost Country, Day One Analysis Report, 2020 – 2025Employee Assistance Program Market Procurement Intelligence, Supplier Intelligence, Supplier Ranking, Pricing & Cost Structure Intelligence, Best Practices, Engagement Model, Low & Best Cost Country, Day One Analysis Report, 2021 – 2025About us:A smart and effective supply chain is essential for growth in any organization. comFollow Us: LinkedIn | Twitter

Clinical Trial Imaging Market 2022 global statistical analysis, growth, solutions, Industry analysis, demand Research Report By 2028

Sns Insider 2022-09-19

A range of primary and secondary records assets are used in Clinical Trial Imaging market studies. com/sample-request/1761Key PlayerBiomedical Systems CorpBio TelemetryCardiovascular Imaging TechnologiesIXICO plcIntrinsic ImagingMed paceNavetas Life SciencesPro scan ImagingResonance HealthRadiant Sage LLCThe Clinical Trial Imaging Market analysis defines the compelling electricity of the segments which might be centered based on CAGR and market size. Based on income, profits, boom fee, and market share, the report classifies the worldwide Clinical Trial Imaging marketplace into wonderful segments. COVID-19 Impact AnalysisThe record investigates the revenue effect of COVID-19 lockdown on Clinical Trial Imaging marketplace leaders, fans, and disruptors. Table Of ContentsIntroductionResearch MethodologyMarket DynamicsImpact AnalysisValue Chain AnalysisPorter’s 5 Forces ModelPEST AnalysisClinical Trial Imaging Market SegmentationRegional AnalysisCompany ProfilesCompetitive LandscapeConclusionCONTACT-USAkash AnandHead Of Business Development and Strategysales@snsinsider.

Clinical Trial Supplies Market worth $ 2.9 billion by 2026 - Exclusive Report by MarketsandMarkets™

marketsandmarkets 2022-07-19

The global clinical trial supplies market is projected to reach USD 2. id=172240059Browse in-depth TOC on "Clinical Trial Supplies Market”237 – Tables47 – Figures242 – PagesThe logistics and distribution segment accounted for the largest share of the services segment in the clinical trial supplies market in 2020. id=172240059The Asia Pacific region is the fastest-growing region of the clinical trial supplies market in 2020. Based on the region, the clinical trial supplies market is broadly segmented into North America, Europe, the Asia Pacific, and the Rest of the World. Prominent players operating in the global clinical trial supplies market include Catalent, Inc.

Global In Silico Clinical Trial Market Trends, Application and Regional Forecast to 2023-2029

James Grey 2023-02-21

Bharat Book Bureau Provides the Trending Market Research Report on “Global In Silico Clinical Trial Market 2023-2029”under Life Sciences Market Research Report Category. The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global in silico clinical trial market. The oncology segment is estimated to account for the largest share of the global in silico clinical trial market. In silico clinical trial market is further segmented by phase: phase I, phase II, phase III, phase IV. Scope of the Report• To analyze and forecast the market size of the global in silico clinical trial market.

WHO TO FOLLOW